Most practitioners start tirzepatide at its lowest dose of 2.5 mg regardless of the previous semaglutide dose to minimize gastrointestinal side effects during the transition
Patients with PCOS Polycystic ovary syndrome creates metabolic challenges that make weight management particularly difficult
Reduced mechanical loading decreases the stimulus for muscle protein synthesis, exacerbating lean tissue loss [31]
Improvements in other health markers, such as blood pressure, cholesterol, and blood sugar, were also experienced by most participants
In reality, cost is a major consideration for these weight loss medications, says Alyssa Dominguez, MD, an endocrinologist with Keck Medicine of USC
Women taking semaglutide who are also on hormonal birth control or HRT face compounded risk factors